Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group Study

This publication has 25 references indexed in Scilit:

• Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: A ten-year follow-up
  Medical and Pediatric Oncology, 1997
• Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
  Journal of Clinical Oncology, 1996
• Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X
  The Lancet, 1995
• Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
  Journal of Clinical Oncology, 1994
• A pilot study of intermediate‐dose methotrexate and cytosine arabinoside, “Spread‐out” or “Up‐front,” in continuation therapy for childhood non‐T, non‐B acute lymphoblastic leukemia a pediatric oncology group study
  Cancer, 1991
• Four-Agent Induction and Intensive Asparaginase Therapy for Treatment of Childhood Acute Lymphoblastic Leukemia
  New England Journal of Medicine, 1986
• Münchner Studie zur Behandlung der akuten lymphoblastischen Leukämie im Kindesalter (ALL 77-02)
  Klinische Padiatrie, 1985
• Comparison of Intermediate-Dose Methotrexate with Cranial Irradiation for the Post-Induction Treatment of Acute Lymphocytic Leukemia in Children
  New England Journal of Medicine, 1983
• The use of intermediate dose methotrexate in increased risk childhood acute lymphoblastic leukemia a comparison of three versus six courses
  Cancer, 1982
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
  British Journal of Cancer, 1977